国产一区二区免费,68精品久久久久久欧美,污污网站在线观看,天天射天天日天天

更新于 5月27日

DMPK Research Investigator (Beijing or Shanghai)) (MJ018327)

1.6-2.2萬
  • 上海浦東新區(qū)
  • 3-5年
  • 碩士
  • 全職
  • 招1人

職位描述

新藥
Responsibilities:
  • Possess a solid understanding of DMPK principles to guide CROs in completing preclinical DMPK packages that support clinical research or regulatory submissions.
  • Collaborate with colleagues from other R&D departments (Chemistry, Toxicology, Pharmacology, Biomarkers, Clinical, etc.) and global regulatory teams to provide DMPK research support during drug development stages.
  • Assist in the preparation and writing of various DMPK submission documents.
  • Represent the team at internal governance meetings, advise on optimal approaches for regulatory reviews and program progression, and ensure compliance with guidelines from all health authorities concerning Development DMPK matters.
Requirements:
  • Master's or Ph.D. degree in Pharmacokinetics or a related field; at least one year of work experience, with preference given to candidates with DMPK or large molecule PK submission experience.
  • Ability to collaborate cross-functionally with colleagues and work independently.
  • Strong scientific insight and problem-solving skills, meticulous attention to detail, and the ability to learn and adapt quickly.
  • Excellent communication and writing skills in both Chinese and English.
  • Proficiency in using GastroPlus, and familiarity with Excel, Word, PowerPoint, and other office software.
百濟(jì)神州全球勝任力 當(dāng)我們通過以下十二項(xiàng)全球勝任力,展現(xiàn)出 "患者為先"、"無界協(xié)作"、"銳意創(chuàng)新 "和 "追求卓越 "的價(jià)值觀時(shí),我們就能幫助全世界更多患者獲得更多負(fù)擔(dān)得起的藥品。 ●團(tuán)隊(duì)協(xié)作 ●提供并征求坦誠(chéng)及可行的反饋 ●自我認(rèn)知 ●兼容并蓄 ●積極主動(dòng) ●開拓精神 ●持續(xù)學(xué)習(xí) ●擁抱變化 ●結(jié)果導(dǎo)向 ●分析性思維/數(shù)據(jù)分析 ●卓越財(cái)務(wù) ●清晰溝通 BeiGene Global Competencies When we exhibit our values of Patients First, Collaborative Spirit, Bold Ingenuity and Driving Excellence, through our twelve global competencies below, we help get more affordable medicines to more patients around the world. ●Fosters Teamwork ●Provides and Solicits Honest and Actionable Feedback ●Self-Awareness ●Acts Inclusively ●Demonstrates Initiative ●Entrepreneurial Mindset ●Continuous Learning ●Embraces Change ●Results-Oriented ●Analytical Thinking/Data Analysis ●Financial Excellence ●Communicates with Clarity 求職者隱私申明: 百濟(jì)神州致力于尊重和保護(hù)您的個(gè)人信息權(quán)利,并承諾依據(jù)合法、正當(dāng)、必要和誠(chéng)信的原則處理您的個(gè)人信息(包括個(gè)人敏感信息 )。 由于百濟(jì)神州在全球范圍內(nèi)開展業(yè)務(wù),我們可能需要基于人力資源管理等合理業(yè)務(wù)目的而將您的個(gè)人信息發(fā)送和/或存儲(chǔ)在位于您所在國(guó)家以外其他國(guó)家(例如:美國(guó))的服務(wù)器和數(shù)據(jù)庫中,詳情參見百濟(jì)神州《求職者隱私政策》(百濟(jì)神州官網(wǎng) - 隱私政策 - 求職者隱私政策)。 如您主動(dòng)向我們提供您的簡(jiǎn)歷信息或其他個(gè)人信息,則視為您已經(jīng)充分理解并確認(rèn)接受百濟(jì)神州《求職者隱私政策》內(nèi)容。如您對(duì)此有任何疑問的,請(qǐng)勿提交簡(jiǎn)歷信息或其他個(gè)人信息。 BeiGene is committed to respect and protect your personal information rights, and will process your personal information, including your sensitive personal information, based on the principles of legality, legitimacy, necessity, and integrity. Due to the reasonable business need for human resource management as a result of BeiGene’s global operation, your personal information may be transferred and/ or stored in a server/database located in a third country (e.g., the United States) other than your own country. For further details, please refer to BeiGene Job Applicant Privacy Policy (BeiGene official website - Privacy Policy - Job Applicant Privacy Policy). If you voluntarily provide your resume or other personal information to us, it is deemed as you have thoroughly acknowledged and accepted BeiGene Job Applicant Privacy Policy. If you have any concern, please DO NOT submit your resume or any other personal information.

工作地點(diǎn)

浦東新區(qū)百濟(jì)神州(上海)醫(yī)藥研發(fā)有限公司

職位發(fā)布者

張婧媛/百濟(jì)神州研發(fā)招聘recruiter

今日活躍
立即溝通
公司Logo百濟(jì)神州北京
About BeiGene BeiGene is a publically traded(BGNE, NASDAQ), globally focused biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer. Our cancer biology platform addresses the importance of tumor-immune system interactions and the value of primary tumor biopsies in developing new cancer models. We have a global team of over 200 individuals, including over 150 scientists and clinicians, and a world-renowned scientific advisory board, with deep scientific talent, extensive pharmaceutical experience, and a commitment to improving the lives of cancer patients around the world. Our clinical pipeline is comprised of novel oral small molecules and monoclonal antibodies(mAb) for cancer, including an anti-PD-1 monoclonal antibody, a best-in-class BTK inhibitor, a RAF dimer inhibitor, a best-in-class PARP inhibitor, and a variety of combination clinical studies. In addition, our robust preclinical programs are expected to generate more small molecule and mAb drugs for clinical development in coming years. For more information, please visit our website at www.beigene.com.
公司主頁
无码专区狠狠躁躁天天躁| 日韩不卡无码高清| 亚洲欧美大全| 精品国日本产在线观看| 香蕉视频日| 国产线路1国产线路2| 真人二十三式性视频(动)| 欧美久草| 另类亚洲欧美精品久久| 激情亚洲国产欧美| 国产精品一区二区 尿失禁| 日本性| 亚洲色图第6页| 欧美图片一区二区| 亚洲Av无码不卡久久| 久久久久久久久久久久久久| av网站大全| 破除 视频 在线 高清| 天堂资源在线| 久青草无码视频在线播放| 国产一二区无吗| 丁香婷婷深情五月亚洲| 日韩欧美第一页| 无锡市| 亚洲综合激情在线| 亚洲ABB国产精品| 伊人久艹| 国产婷婷色综合AV蜜臀AV| 亚洲综合欧美在线一区在线播放| 四虎视频| 久久精品紧身裙丝袜女老师| 91AV小视屏| 先锋影音亚洲av每日资源网站| 久草爆乳| 97人人草| 精品伦精品一区二区三区视频密桃| 日韩欧美性爱| 成人一区电影| 在线精品精| 中文字幕人妻偷人伦在线视频 | 人人干人人谢|